These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16432693)

  • 21. Improvements in motor behavioral tests during deep brain stimulation of the subthalamic nucleus in rats with different degrees of unilateral parkinsonism.
    Fang X; Sugiyama K; Akamine S; Namba H
    Brain Res; 2006 Nov; 1120(1):202-10. PubMed ID: 16997286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The footfault test as a screening tool in the 6-hydroxydopamine rat model of Parkinson's disease.
    Silvestrin RB; de Oliveira LF; Batassini C; Oliveira A; e Souza TM
    J Neurosci Methods; 2009 Mar; 177(2):317-21. PubMed ID: 19026686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease.
    Schlachetzki JC; Marxreiter F; Regensburger M; Kulinich A; Winner B; Winkler J
    Restor Neurol Neurosci; 2014; 32(4):447-62. PubMed ID: 24604006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of electroacupuncture on proteomic changes in the motor cortex of 6-OHDA Parkinsonian rats.
    Li M; Li L; Wang K; Su W; Jia J; Wang X
    Brain Res; 2017 Oct; 1673():52-63. PubMed ID: 28760440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasally applied L-DOPA alleviates parkinsonian symptoms in rats with unilateral nigro-striatal 6-OHDA lesions.
    Chao OY; Mattern C; Silva AM; Wessler J; Ruocco LA; Nikolaus S; Huston JP; Pum ME
    Brain Res Bull; 2012 Feb; 87(2-3):340-5. PubMed ID: 22108632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease.
    Ambrosi G; Armentero MT; Levandis G; Bramanti P; Nappi G; Blandini F
    Brain Res Bull; 2010 Apr; 82(1-2):29-38. PubMed ID: 20100549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
    Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
    J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model.
    Branchi I; D'Andrea I; Armida M; Cassano T; Pèzzola A; Potenza RL; Morgese MG; Popoli P; Alleva E
    J Neurosci Res; 2008 Jul; 86(9):2050-61. PubMed ID: 18335518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats.
    Inaji M; Okauchi T; Ando K; Maeda J; Nagai Y; Yoshizaki T; Okano H; Nariai T; Ohno K; Obayashi S; Higuchi M; Suhara T
    Brain Res; 2005 Dec; 1064(1-2):136-45. PubMed ID: 16298352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioural effects of parafascicular thalamic lesions in an animal model of parkinsonism.
    Henderson JM; Schleimer SB; Allbutt H; Dabholkar V; Abela D; Jovic J; Quinlivan M
    Behav Brain Res; 2005 Jul; 162(2):222-32. PubMed ID: 15970217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis.
    Carmo MR; Menezes AP; Nunes AC; Pliássova A; Rolo AP; Palmeira CM; Cunha RA; Canas PM; Andrade GM
    Neuropharmacology; 2014 Jun; 81():142-52. PubMed ID: 24508709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism.
    Senthilkumar KS; Saravanan KS; Chandra G; Sindhu KM; Jayakrishnan A; Mohanakumar KP
    Behav Brain Res; 2007 Nov; 184(1):11-8. PubMed ID: 17765334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The NK1 receptor antagonist N-acetyl-L-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model.
    Thornton E; Hassall MM; Corrigan F; Vink R
    Parkinsonism Relat Disord; 2014 May; 20(5):508-13. PubMed ID: 24637127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nigral 6-hydroxydopamine lesion impairs performance in a lateralised choice reaction time task--impact of training and task parameters.
    Lindgren HS; Klein A; Dunnett SB
    Behav Brain Res; 2014 Jun; 266():207-15. PubMed ID: 24613237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of diazepam efficacy on anxiety-like behavior in hemiparkinsonian rats.
    O'Connor KA; Feustel PJ; Ramirez-Zamora A; Molho E; Pilitsis JG; Shin DS
    Behav Brain Res; 2016 Mar; 301():226-37. PubMed ID: 26748254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reductions in spontaneous locomotor activity in aged male, but not female, rats in a model of early Parkinson's disease.
    Cass WA; Peters LE; Smith MP
    Brain Res; 2005 Feb; 1034(1-2):153-61. PubMed ID: 15713267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repetitive vibrissae-elicited forelimb placing before and immediately after unilateral 6-hydroxydopamine improves outcome in a model of Parkinson's disease.
    Anstrom KK; Schallert T; Woodlee MT; Shattuck A; Roberts DC
    Behav Brain Res; 2007 May; 179(2):183-91. PubMed ID: 17374405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease.
    Delattre AM; Kiss A; Szawka RE; Anselmo-Franci JA; Bagatini PB; Xavier LL; Rigon P; Achaval M; Iagher F; de David C; Marroni NA; Ferraz AC
    Neurosci Res; 2010 Mar; 66(3):256-64. PubMed ID: 19941911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.